Literature DB >> 18533658

Peptide probes for protein transmembrane domains.

Peter F Slivka1, Johnny Wong, Gregory A Caputo, Hang Yin.   

Abstract

Much current interest in chemical biology focuses on the transmembrane domains of proteins, which have emerged as targets for the development of novel diagnostics and therapeutics. Integral membrane proteins are a group of important biomolecules that play pivotal roles in many cellular activities. Previous studies primarily focused on the extra- and/or intracellular domains of membrane proteins. However, the importance of transmembrane regions in the regulation of protein complexes is beginning to emerge. As such, a number of methods for designing and testing novel exogenous peptides that recognize transmembrane targets and modulate cellular functions have been developed. This Review outlines current methodologies for developing these transmembrane probes that may provide useful tools to study a variety of biological phenomena in the membrane.

Mesh:

Substances:

Year:  2008        PMID: 18533658     DOI: 10.1021/cb800049w

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  4 in total

Review 1.  Interaction and conformational dynamics of membrane-spanning protein helices.

Authors:  Dieter Langosch; Isaiah T Arkin
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 2.  Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.

Authors:  Justin M Westerfield; Francisco N Barrera
Journal:  J Biol Chem       Date:  2019-12-25       Impact factor: 5.157

3.  Using two fluorescent probes to dissect the binding, insertion, and dimerization kinetics of a model membrane peptide.

Authors:  Jia Tang; Hang Yin; Jade Qiu; Matthew J Tucker; William F DeGrado; Feng Gai
Journal:  J Am Chem Soc       Date:  2009-03-25       Impact factor: 15.419

4.  Isolated Toll-like receptor transmembrane domains are capable of oligomerization.

Authors:  James I Godfroy; Mohammad Roostan; Yurii S Moroz; Ivan V Korendovych; Hang Yin
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.